Nilgun Cinar

Nilgun Cinar

Auto-generated profile, based on publicly available information

Nilgun Cinar

Department of Neurology, Maltepe University, Faculty of Medicine, Istanbul, Türkiye

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
NÇNilgün Çinar
Nilgün Çinar
TŞTürker Ahmet Hasan Şahiner
Türker Ahmet Hasan Şahiner
Clinical trials conducted on the efficacy of computerized cognitive training (CCT) programs have not led to any important breakthroughs. CCT is a safe and inexpensive approach, but its efficacy in patients on rivastigmine therapy has not been evaluated. This study aims to compare effects of CCT and examines rivastigmine to determine whether CCT has any further contributions to make. Sixty individuals with subjective memory complaint (SCI) and 60 individuals with early stage Alzheimer’s dementia (AD) were subjected to the Montreal Cognitive Assessment (MoCA), Cambridge Cognition (CANTAB tests: MOT, PRM, DMS, SWM, PAL, RTI), and Bayer-ADL. After screening patients who were diagnosed with AD, we started rivastigmine patch treatment (10 cm2 = 9.5 mg). The SCI and AD groups were randomly divided, and one each of the SCI and AD groups were accessed using BEYNEX, a web-based program. After a minimum of at least 1200 min of use, the diagnostic tests were repeated. The AD groups’ MoCA scores of the BEYNEX-practicing group demonstrated meaningfully increase, whereas they decreased in the control group, and the Bayer-ADL scores indicated improvement in ADL. The CANTAB tests both in SCI and AD and in groups using BEYNEX showed positive improvement in MOT, DMS, and PAL data. This study is a rare example that focuses on both groups with SCI and AD. The efficacy of CCT varies across cognitive domains and shows significant efficacy for AD but small improvements in cognitively healthy older adults. In future studies, integration with a smart learning algorithm may lead to interesting observations on which parameters are more sensitive to change under long-term use of CCT in a large number of subjects.

1 October 2013 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
NCN. Cinar
N. Cinar
SSSevki Sahin
Sevki Sahin
TOT. Okluoglu Onay
T. Okluoglu Onay
SKS. Karsidag
S. Karsidag

1 September 2020 in Stroke Research and Treatment
Verified
Journal Article
Open access
PDF file
DUDerya Uludüz
Derya Uludüz
SSSevki Sahin
Sevki Sahin
TDTaskin Duman
Taskin Duman
SOSerefnur Ozturk
Serefnur Ozturk
VYVildan Yayla
Vildan Yayla
TGTaskin Gunes
Taskin Gunes
Background. Early diagnosis of cerebral venous sinus thrombosis (CVST) associated with reproductive health-related risk factors (RHRF) including pregnancy, puerperium, and oral contraceptive (OC) use can prevent severe neurological sequelae; thus, the symptoms must be documented in detail for each group. Methods. Out of 1144 patients with CVST, a total of 777 women were enrolled from a multicenter for the study of cerebral venous sinus thrombosis (VENOST). Demographic, biochemical, clinical, and radiological aspects were compared for 324 cases with RHRF and 453 cases without RHRF. Results. The mean age of the RHRF (-) group (43.2 ± 13 years) was significantly higher than of the RHRF (+) group (34±9 years). A previous history of deep venous thrombosis (3%), isolated cavernous sinus involvement (1%), cranial neuropathy (13%), comorbid malignancy (7%), and its disability scores after 12 months (9%) were significantly higher in the RHRF (-) group. The RHRF (+) group consisted of 44% cases of puerperium, 33% cases of OC users and 23% of pregnant women. The mean age was found to be higher in OC users (38±9 years). A previous history of deep venous thrombosis was slightly higher in the pregnancy subgroup (4%). Epileptic seizures were more common in the puerperium group (44%). Conclusion. The results of our study indicate that the risk of CSVT increases parallel to age, OC use, and puerperium period. In addition, when considering the frequency of findings and symptoms, epileptic seizures in the puerperium subgroup of the RHRF (+) group and malignancies in the RHRF (-) group may accompany the CSVT. In daily practice, predicting these risks for the CSVT and early recognition of the symptoms will provide significant benefits to patients.


22 December 2023 in Epilepsy & Behavior
Verified
Journal Article
Closed access
GAGönül Akdağ
Gönül Akdağ
SKSibel Canbaz Kabay
Sibel Canbaz Kabay
ADAylin Bican Demir
Aylin Bican Demir
EBEbru Ergin Bakar
Ebru Ergin Bakar
GKGüray Koç
Güray Koç
MÇMustafa Çetiner
Mustafa Çetiner

19 August 2021 in Cureus
Verified
Journal Article
Open access
SKSibel Karsidag
Sibel Karsidag
SSSevki Sahin
Sevki Sahin
MAMiruna F. Ates
Miruna F. Ates
NCNilgun Cinar
Nilgun Cinar
SKSude Kendirli
Sude Kendirli
Neurological diseases related to coronavirus disease-2019 (COVID-19) are increasingly reported. We report here three cases that presented with subtle neurologic findings manifesting within a range of 15 days to four months after their COVID-19 diagnoses. Magnetic resonance imaging showed acute multifocal periventricular and subcortical demyelinating lesions. Some of the lesions showed contrast enhancement and diffusion restriction. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PCR was found in the cerebrospinal fluid of just one patient. All patients received intravenous methylprednisolone therapy. In this report, we aim to discuss the aspects of possible COVID-19-related demyelination that support a diagnosis of multiple sclerosis (MS) or acute disseminated encephalomyelitis (ADEM).